A study on non-small cell lung cancer (NSCLC) therapeutic resistance identified a role of miR-146b-5p in downregulating IRAK1, thereby enhancing the sensitivity to EGFR tyrosine kinase inhibitors (TKIs). This evidence concerns the gene EGFR and non-small cell lung carcinoma.